Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société OPGEN, INC.
06/09OPGEN  : Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
PU
06/09OPGEN INC  : Submission of Matters to a Vote of Security Holders, Other Events, ..
AQ
06/09OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
GL
06/09OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webina..
GL
06/07OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move t..
GL
06/01OPGEN  : Corporate Presentation (PDF)
PU
05/14OPGEN  : Note 2 - Going Concern and Management's Plans
AQ
05/14OPGEN  : Reports First Quarter 2021 Financial Results and Provides Business Upda..
PU
05/13OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
05/13OpGen Reports First Quarter 2021 Financial Results and Provides Business Upda..
GL
05/02OPGEN  : Corporate Presentation (PDF)
PU
04/29OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 a.m. Eastern Time
GL
04/19OPGEN  : Corporate Presentation (PDF)
PU
04/19OpGen Extends and Expands Partnership with New York State Department of Healt..
GL
04/12OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-inf..
GL
03/30OPGEN  : Corporate Presentation (PDF)
PU
03/29OPGEN  : Management's Discussion and Analysis of Financial Condition and Results..
AQ
03/25OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
03/25OPGEN  : Reports Fourth Quarter and Full Year 2020 Financial Results and Provide..
AQ
03/11OpGen to Provide Business Update and Financial Results for the Fourth Quarter..
GL
03/09OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
03/08OPGEN INC  : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
03/08OPGEN  : Corporate Presentation (PDF)
PU
03/08OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for D..
GL
03/02OPGEN  : Corporate Presentation (PDF)
PU
03/01OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
GL
02/16OPGEN  : Corporate Presentation (PDF)
PU
02/16OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Bes..
GL
02/10OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
02/09OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Ma..
GL
02/01OPGEN  : Corporate Presentation (PDF)
PU
01/13OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
01/13OPGEN  : Corporate Presentation (PDF)
PU
01/13OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Bu..
GL
01/05OPGEN  : Corporate Presentation (PDF)
PU
01/05OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnershi..
GL
2020RESULTS FROM 1,400 PATIENT SAMPLE MU : Unyvero LRT BAL Panel Provides Accurate D..
AQ
2020OpGen Announces Planned Leadership Transition at Next Generation Sequencing a..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Pres..
GL
2020OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
2020OPGEN  : Announces $10 Million Private Placement Priced at the Market
AQ
2020OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
GL
2020OPGEN  : Note 2 - Liquidity and management's plans
AQ
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN INC  : Entry into a Material Definitive Agreement, Other Events, Financial..
AQ
2020OPGEN  : Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Tes..
AQ
2020OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic ..
GL
2020OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
2020OPGEN  : Reports Third Quarter 2020 Financial Results and Provides Business Upda..
AQ
2020OpGen Reports Third Quarter 2020 Financial Results and Provides Business Upda..
GL
2020OPGEN INC  : Change in Directors or Principal Officers, Financial Statements and..
AQ
2020OPGEN  : to Provide Business Update and Financial Results for the Third Quarter ..
AQ
2020OpGen to Provide Business Update and Financial Results for the Third Quarter ..
GL
2020OPGEN  : Announces Award of German Government Grant Funding to its Subsidiary Cu..
AQ
2020OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN INC  : Results of Operations and Financial Condition (form 8-K)
AQ
2020OPGEN  : Provides Business and Pipeline Update and Announces Preliminary Unaudit..
AQ
2020OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudit..
GL
2020OPGEN  : Issues Formal Response to FDA's Requests for Additional Information and..
AQ
2020OpGen Issues Formal Response to FDA's Requests for Additional Information and..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN  : Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
AQ
2020OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-g..
GL
2020OPGEN INC  : Change in Directors or Principal Officers, Submission of Matters to..
AQ
2020OPGEN  : Announces Award of German Government Grant Funding to its Subsidiary Cu..
AQ
2020OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
2020OPGEN  : Announces Successful Completion of Study Collaboration with Karolinska ..
AQ
2020OpGen Announces Successful Completion of Study Collaboration with Karolinska ..
GL
2020OPGEN  : Announces Notice of Annual Meeting Venue Change
AQ
2020OpGen, Inc. Announces Notice of Annual Meeting Venue Change
GL
2020OPGEN  : Collaborative Research by OpGen Group Company Ares Genetics and Johns H..
AQ
2020Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
1  2  3Next
Upcoming event on OPGEN, INC.